The rapid advancement of cell and gene therapies is transforming the treatment landscape for cancer, rare genetic disorders, autoimmune diseases, and other chronic conditions. As the number of clinical trials and regulatory approvals continues to grow, pharmaceutical and biotechnology companies are increasingly relying on specialized partners to accelerate product development. This shift has...